The focus of the debates surrounding the Medical Innovation Bill and Access to Medical Treatments (Innovation) Act 2015 was the negligence provisions. This paper examines the other aspect that was consequently ignored: the proposed database of innovative treatments of Lord Saatchi’s Bill. It is argued that some aspects of the database require rethinking, but that its biggest problem lies in the lack of stakeholder clamour for it
That doctors are more likely to be sued for negligence now than they have been in the past is undeni...
The real impact of the Health Care reforms depends not on their design but on their implementation. ...
Purpose of this discussion paper This paper is being released to promote discussion and to assist th...
The focus of the debates surrounding the Medical Innovation Bill and Access to Medical Treatments (I...
Lord Saatchi’s Medical Innovation Bill, which has been reintroduced into parliament, is a deeply fla...
Objective: This paper aims to demonstrate that any suggestion that there is a need for specific inno...
In 2014, Lord Saatchi launched his ultimately unsuccessful Medical Innovation Bill in the UK. Its la...
The current debate surrounding the Medical Innovation Bill purports to be aimed at improving the nor...
open access articleIn 2014, Lord Saatchi launched his ultimately unsuccessful Medical Innovation Bil...
This special issue features papers culminating from a six seminar ESRC series ‘Liability versus inno...
This thesis has proposed a fourth model of contact between patient and doctor, that of innovation. T...
From the late nineteenth century onwards there emerged an increasingly diverse response to escalatin...
The questions tackled in this paper are: How do we deal with ethically contested medical innovations...
During 2011 health law grew by the addition of eight new Regulations dealing with stem cells and rel...
Human biological material is an invaluable resource for medical research and contributes to the deve...
That doctors are more likely to be sued for negligence now than they have been in the past is undeni...
The real impact of the Health Care reforms depends not on their design but on their implementation. ...
Purpose of this discussion paper This paper is being released to promote discussion and to assist th...
The focus of the debates surrounding the Medical Innovation Bill and Access to Medical Treatments (I...
Lord Saatchi’s Medical Innovation Bill, which has been reintroduced into parliament, is a deeply fla...
Objective: This paper aims to demonstrate that any suggestion that there is a need for specific inno...
In 2014, Lord Saatchi launched his ultimately unsuccessful Medical Innovation Bill in the UK. Its la...
The current debate surrounding the Medical Innovation Bill purports to be aimed at improving the nor...
open access articleIn 2014, Lord Saatchi launched his ultimately unsuccessful Medical Innovation Bil...
This special issue features papers culminating from a six seminar ESRC series ‘Liability versus inno...
This thesis has proposed a fourth model of contact between patient and doctor, that of innovation. T...
From the late nineteenth century onwards there emerged an increasingly diverse response to escalatin...
The questions tackled in this paper are: How do we deal with ethically contested medical innovations...
During 2011 health law grew by the addition of eight new Regulations dealing with stem cells and rel...
Human biological material is an invaluable resource for medical research and contributes to the deve...
That doctors are more likely to be sued for negligence now than they have been in the past is undeni...
The real impact of the Health Care reforms depends not on their design but on their implementation. ...
Purpose of this discussion paper This paper is being released to promote discussion and to assist th...